有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | ethyl (2S)-3-[2-(4-bromophenyl)sulfanylethylimino]-2-cyanopropanoate | —— | C14H15BrN2O2S |
|
—— | (2S)-5-[(4,5-dimethyl-1,2,4-triazol-3-yl)sulfanyl]-2-methyl-2-(propylamino)pentanenitrile | —— | C13H23N5S |
|
—— | (2S)-6-[(4,5-dimethyl-1,2,4-triazol-3-yl)sulfanyl]-2-methyl-2-(methylamino)hexanenitrile | —— | C12H21N5S |
|
—— | ethyl (2S)-2-cyano-3-[2-(4-methylphenyl)sulfanylethylimino]propanoate | —— | C15H18N2O2S |
|
—— | (E)-3-[[5-[(4-methylphenyl)methylsulfanyl]-1,3,4-thiadiazol-2-yl]amino]-2-(4-methyl-1,3-thiazol-2-yl)prop-2-enenitrile | —— | C17H15N5S3 |
|
—— | (2R)-6-[(4,5-dimethyl-1,2,4-triazol-3-yl)sulfanyl]-2-methyl-2-(methylamino)hexanenitrile | —— | C12H21N5S |
|
—— | 2-(4-amino-5-cyanopyrimidin-2-yl)sulfanyl-N-[(4-methylphenyl)methyl]-N-propylacetamide | —— | C18H21N5OS |
|
—— | ethyl (E)-3-[2-[2-(4-chlorophenyl)sulfanylacetyl]hydrazinyl]-2-cyanoprop-2-enoate | —— | C14H14ClN3O3S |
|
—— | N-cyclopropyl-N-[(2-fluorophenyl)methyl]-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylacetamide | —— | C19H22FN3OS |
|
—— | N-propyl-N-[(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)methyl]-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylacetamide | —— | C19H23N5O2S2 |
|
—— | N-[(2R)-butan-2-yl]-N-[(3R)-1,1-dioxothiolan-3-yl]-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylacetamide | —— | C17H27N3O3S2 |
|
—— | N-[(2S)-butan-2-yl]-N-[(3R)-1,1-dioxothiolan-3-yl]-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylacetamide | —— | C17H27N3O3S2 |
|
—— | N-[2-(3-chlorophenyl)ethyl]-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylacetamide | —— | C17H20ClN3OS |
|
—— | N-(3-phenylsulfanylpropyl)-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylacetamide | —— | C18H23N3OS2 |
|
—— | N-[[4-(dimethylamino)phenyl]methyl]-N-methyl-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylacetamide | —— | C19H26N4OS |
|
—— | N-[[5-(4-chlorophenyl)furan-2-yl]methyl]-N-methyl-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylacetamide | —— | C21H22ClN3O2S |
|
—— | N-(2-methylbutan-2-yl)-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylacetamide | —— | C14H23N3OS |
|
—— | 2-(4-Methylphenyl)-4-[(4,5,6-trimethylpyrimidin-2-yl)sulfanylmethyl]-1,3-thiazole | —— | C18H19N3S2 |
|
—— | 2-(4-amino-5-cyanopyrimidin-2-yl)sulfanyl-N-[(2S)-5-methylhexan-2-yl]acetamide | —— | C14H21N5OS |
|
—— | 4-Amino-2-[2-(azocan-1-yl)-2-oxoethyl]sulfanylpyrimidine-5-carbonitrile | —— | C14H19N5OS |
|
—— | 1-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylethanone | —— | C20H23N3OS |
|
—— | (2S)-3-[(4,5-dimethyl-1,2,4-triazol-3-yl)sulfanyl]-2-methyl-2-(propan-2-ylamino)propanenitrile | —— | C11H19N5S |
|
—— | (2S)-2-(cyclopropylamino)-4-[(4,5-dimethyl-1,2,4-triazol-3-yl)sulfanyl]butanenitrile | —— | C11H17N5S |
|
—— | (2S)-4-[(4,5-dimethyl-1,2,4-triazol-3-yl)sulfanyl]-2-methyl-2-(propylamino)butanenitrile | —— | C12H21N5S |
|
—— | N-benzyl-2-(2,5-dimethylphenyl)sulfanyl-N-[(3S)-1,1-dioxo-2,3-dihydrothiophen-3-yl]acetamide | —— | C21H23NO3S2 |
|
—— | 2-(4-amino-5-cyanopyrimidin-2-yl)sulfanyl-N-[(2R)-6-methylheptan-2-yl]acetamide | —— | C15H23N5OS |
|
—— | 2-(4-amino-5-cyanopyrimidin-2-yl)sulfanyl-N-[(1S)-1-(furan-2-yl)ethyl]acetamide | —— | C13H13N5O2S |
|
—— | 2-(4-amino-5-cyanopyrimidin-2-yl)sulfanyl-N-[(1R)-1-(furan-2-yl)ethyl]acetamide | —— | C13H13N5O2S |
|
—— | 4-Amino-2-[(5-phenyl-1,2-oxazol-3-yl)methylsulfanyl]pyrimidine-5-carbonitrile | —— | C15H11N5OS |
|
—— | (2R)-2-(cyclopropylamino)-4-[(4,5-dimethyl-1,2,4-triazol-3-yl)sulfanyl]butanenitrile | —— | C11H17N5S |
|
—— | 2-(5-Bromothiophen-2-yl)-5-[(2,4-dimethylphenyl)sulfanylmethyl]-1,3,4-oxadiazole | —— | C15H13BrN2OS2 |
|
—— | 2-(4-amino-5-cyanopyrimidin-2-yl)sulfanyl-N-[(S)-(4-fluorophenyl)-thiophen-2-ylmethyl]acetamide | —— | C18H14FN5OS2 |
|
—— | 2-(4-amino-5-cyanopyrimidin-2-yl)sulfanyl-N-(2,4,4-trimethylpentan-2-yl)acetamide | —— | C15H23N5OS |
|
—— | (2R)-3-[(4,5-dimethyl-1,2,4-triazol-3-yl)sulfanyl]-2-methyl-2-(propan-2-ylamino)propanenitrile | —— | C11H19N5S |
|
—— | (2R)-4-[(4,5-dimethyl-1,2,4-triazol-3-yl)sulfanyl]-2-methyl-2-(propylamino)butanenitrile | —— | C12H21N5S |
|
—— | 2-[[4-Methyl-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanylmethyl]-5-(3-methylphenyl)-1,3,4-oxadiazole | —— | C18H17N5O2S |
|
—— | N-[(2R)-2-ethylhexyl]-2-[[4-methyl-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C18H28N4O2S |
|
—— | N-[2-(4-bromophenyl)sulfanylethyl]-2-(4,6-diaminopyrimidin-2-yl)sulfanylacetamide | —— | C14H16BrN5OS2 |
|
—— | 2-(4,6-diaminopyrimidin-2-yl)sulfanyl-N-hexylacetamide | —— | C12H21N5OS |
|
—— | (2R)-2-(4,6-diaminopyrimidin-2-yl)sulfanyl-N-(furan-2-ylmethyl)propanamide | —— | C12H15N5O2S |
|
—— | 2-(4,6-diaminopyrimidin-2-yl)sulfanyl-N-[[4-(dimethylamino)phenyl]methyl]-N-methylacetamide | —— | C16H22N6OS |
|
—— | 2-(4,6-diaminopyrimidin-2-yl)sulfanyl-N-(3-propan-2-yloxypropyl)acetamide | —— | C12H21N5O2S |
|
—— | 2-(4,6-diaminopyrimidin-2-yl)sulfanyl-N-[(4-ethylphenyl)methyl]-N-methylacetamide | —— | C16H21N5OS |
|
—— | 2-(4,6-diaminopyrimidin-2-yl)sulfanyl-N-[(R)-phenyl(thiophen-2-yl)methyl]acetamide | —— | C17H17N5OS2 |
|
—— | 2-(4,6-diaminopyrimidin-2-yl)sulfanyl-N-[(1R)-1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-methylpropyl]acetamide | —— | C19H25N5O3S |
|
—— | 2-(2-Ethoxyethylsulfanyl)pyrimidine-4,6-diamine | —— | C8H14N4OS |
|
—— | Butyl 2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]acetate | —— | C10H16N4O2S |
|
—— | 2-(4,6-diaminopyrimidin-2-yl)sulfanyl-N-[4-(2-methylbutan-2-yl)cyclohexyl]acetamide | —— | C17H29N5OS |
|
—— | 2-(4,6-diaminopyrimidin-2-yl)sulfanyl-N-[(1S)-1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-methylpropyl]acetamide | —— | C19H25N5O3S |
|
—— | N-cyclopropyl-2-(4,6-diaminopyrimidin-2-yl)sulfanyl-N-[(2-fluorophenyl)methyl]acetamide | —— | C16H18FN5OS |
|